Brief Report: HIV-1 Resistance Analysis of Participants With HIV-1 and Hepatitis B Initiating Therapy With Bictegravir/Emtricitabine/Tenofovir Alafenamide or Dolutegravir Plus Emtricitabine/Tenofovir Disoproxil Fumarate: A Subanalysis of ALLIANCE Data: Erratum.
出版信息
J Acquir Immune Defic Syndr. 2024 Oct 1;97(2):202. doi: 10.1097/QAI.0000000000003494.
PMID:39250654
Abstract
摘要
Zotero 插件